Logo image of CVE

CENOVUS ENERGY INC (CVE) Stock Fundamental Analysis

NYSE:CVE - New York Stock Exchange, Inc. - CA15135U1093 - Common Stock - Currency: USD

14.645  +0.38 (+2.63%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CVE. CVE was compared to 213 industry peers in the Oil, Gas & Consumable Fuels industry. CVE has only an average score on both its financial health and profitability. CVE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CVE was profitable.
CVE had a positive operating cash flow in the past year.
Of the past 5 years CVE 4 years were profitable.
Each year in the past 5 years CVE had a positive operating cash flow.
CVE Yearly Net Income VS EBIT VS OCF VS FCFCVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

CVE has a Return On Assets of 4.95%. This is comparable to the rest of the industry: CVE outperforms 59.62% of its industry peers.
CVE has a Return On Equity (9.30%) which is in line with its industry peers.
CVE's Return On Invested Capital of 7.38% is fine compared to the rest of the industry. CVE outperforms 61.97% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CVE is significantly below the industry average of 23.55%.
The last Return On Invested Capital (7.38%) for CVE is well below the 3 year average (11.92%), which needs to be investigated, but indicates that CVE had better years and this may not be a problem.
Industry RankSector Rank
ROA 4.95%
ROE 9.3%
ROIC 7.38%
ROA(3y)8.18%
ROA(5y)3.66%
ROE(3y)15.96%
ROE(5y)7.2%
ROIC(3y)11.92%
ROIC(5y)N/A
CVE Yearly ROA, ROE, ROICCVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

CVE has a Profit Margin (5.15%) which is in line with its industry peers.
CVE's Profit Margin has declined in the last couple of years.
CVE's Operating Margin of 8.54% is on the low side compared to the rest of the industry. CVE is outperformed by 63.85% of its industry peers.
CVE's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 32.07%, CVE is in line with its industry, outperforming 42.25% of the companies in the same industry.
CVE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.54%
PM (TTM) 5.15%
GM 32.07%
OM growth 3Y-3.42%
OM growth 5Y2.33%
PM growth 3Y68.65%
PM growth 5Y-12.05%
GM growth 3Y-13%
GM growth 5Y-11.02%
CVE Yearly Profit, Operating, Gross MarginsCVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CVE is creating some value.
The number of shares outstanding for CVE has been reduced compared to 1 year ago.
CVE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CVE is higher compared to a year ago.
CVE Yearly Shares OutstandingCVE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CVE Yearly Total Debt VS Total AssetsCVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

CVE has an Altman-Z score of 2.39. This is not the best score and indicates that CVE is in the grey zone with still only limited risk for bankruptcy at the moment.
CVE has a better Altman-Z score (2.39) than 73.24% of its industry peers.
CVE has a debt to FCF ratio of 3.53. This is a good value and a sign of high solvency as CVE would need 3.53 years to pay back of all of its debts.
CVE's Debt to FCF ratio of 3.53 is fine compared to the rest of the industry. CVE outperforms 74.18% of its industry peers.
CVE has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.34, CVE perfoms like the industry average, outperforming 58.22% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.53
Altman-Z 2.39
ROIC/WACC0.92
WACC7.99%
CVE Yearly LT Debt VS Equity VS FCFCVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

A Current Ratio of 1.46 indicates that CVE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.46, CVE is in the better half of the industry, outperforming 64.79% of the companies in the same industry.
CVE has a Quick Ratio of 1.46. This is a bad value and indicates that CVE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.84, CVE perfoms like the industry average, outperforming 40.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.46
Quick Ratio 0.84
CVE Yearly Current Assets VS Current LiabilitesCVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

The earnings per share for CVE have decreased strongly by -38.43% in the last year.
Measured over the past years, CVE shows a very strong growth in Earnings Per Share. The EPS has been growing by 33.97% on average per year.
Looking at the last year, CVE shows a small growth in Revenue. The Revenue has grown by 1.57% in the last year.
CVE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.88% yearly.
EPS 1Y (TTM)-38.43%
EPS 3Y87.2%
EPS 5Y33.97%
EPS Q2Q%-24.19%
Revenue 1Y (TTM)1.57%
Revenue growth 3Y5.4%
Revenue growth 5Y21.88%
Sales Q2Q%-0.73%

3.2 Future

CVE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.52% yearly.
Based on estimates for the next years, CVE will show a decrease in Revenue. The Revenue will decrease by -5.74% on average per year.
EPS Next Y6.62%
EPS Next 2Y18.58%
EPS Next 3Y19.52%
EPS Next 5YN/A
Revenue Next Year-8.98%
Revenue Next 2Y-4.96%
Revenue Next 3Y-5.74%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CVE Yearly Revenue VS EstimatesCVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
CVE Yearly EPS VS EstimatesCVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2 3

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.44 indicates a correct valuation of CVE.
CVE's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 26.60. CVE is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 8.66, the valuation of CVE can be described as reasonable.
CVE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CVE is cheaper than 74.65% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.39. CVE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 13.44
Fwd PE 8.66
CVE Price Earnings VS Forward Price EarningsCVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CVE indicates a somewhat cheap valuation: CVE is cheaper than 74.18% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CVE is valued a bit cheaper than the industry average as 68.54% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.92
EV/EBITDA 4.52
CVE Per share dataCVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as CVE's earnings are expected to grow with 19.52% in the coming years.
PEG (NY)2.03
PEG (5Y)0.4
EPS Next 2Y18.58%
EPS Next 3Y19.52%

6

5. Dividend

5.1 Amount

CVE has a Yearly Dividend Yield of 4.43%, which is a nice return.
CVE's Dividend Yield is comparable with the industry average which is at 6.74.
Compared to an average S&P500 Dividend Yield of 2.39, CVE pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.43%

5.2 History

On average, the dividend of CVE grows each year by 31.72%, which is quite nice.
CVE has been paying a dividend for at least 10 years, so it has a reliable track record.
CVE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)31.72%
Div Incr Years4
Div Non Decr Years4
CVE Yearly Dividends per shareCVE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

CVE pays out 57.77% of its income as dividend. This is a bit on the high side, but may be sustainable.
CVE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP57.77%
EPS Next 2Y18.58%
EPS Next 3Y19.52%
CVE Yearly Income VS Free CF VS DividendCVE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B
CVE Dividend Payout.CVE Dividend Payout, showing the Payout Ratio.CVE Dividend Payout.PayoutRetained Earnings

CENOVUS ENERGY INC

NYSE:CVE (6/13/2025, 12:00:02 PM)

14.645

+0.38 (+2.63%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners50.86%
Inst Owner Change3.44%
Ins Owners0.81%
Ins Owner ChangeN/A
Market Cap26.69B
Analysts79.09
Price Target19.19 (31.03%)
Short Float %1.01%
Short Ratio1.11
Dividend
Industry RankSector Rank
Dividend Yield 4.43%
Yearly Dividend0.61
Dividend Growth(5Y)31.72%
DP57.77%
Div Incr Years4
Div Non Decr Years4
Ex-Date06-13 2025-06-13 (0.2)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-23.65%
Min EPS beat(2)-72.97%
Max EPS beat(2)25.67%
EPS beat(4)1
Avg EPS beat(4)-18.6%
Min EPS beat(4)-72.97%
Max EPS beat(4)25.67%
EPS beat(8)4
Avg EPS beat(8)-6.58%
EPS beat(12)6
Avg EPS beat(12)-10.49%
EPS beat(16)7
Avg EPS beat(16)-21.6%
Revenue beat(2)0
Avg Revenue beat(2)-7.93%
Min Revenue beat(2)-10.43%
Max Revenue beat(2)-5.43%
Revenue beat(4)2
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-10.43%
Max Revenue beat(4)9.24%
Revenue beat(8)4
Avg Revenue beat(8)-0.09%
Revenue beat(12)7
Avg Revenue beat(12)5.76%
Revenue beat(16)11
Avg Revenue beat(16)6.01%
PT rev (1m)-1.65%
PT rev (3m)-6.57%
EPS NQ rev (1m)-33.97%
EPS NQ rev (3m)-39.39%
EPS NY rev (1m)0%
EPS NY rev (3m)-19.07%
Revenue NQ rev (1m)0.43%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.01%
Valuation
Industry RankSector Rank
PE 13.44
Fwd PE 8.66
P/S 0.67
P/FCF 11.92
P/OCF 4.41
P/B 1.21
P/tB 1.34
EV/EBITDA 4.52
EPS(TTM)1.09
EY7.44%
EPS(NY)1.69
Fwd EY11.55%
FCF(TTM)1.23
FCFY8.39%
OCF(TTM)3.32
OCFY22.7%
SpS21.8
BVpS12.09
TBVpS10.91
PEG (NY)2.03
PEG (5Y)0.4
Profitability
Industry RankSector Rank
ROA 4.95%
ROE 9.3%
ROCE 9.36%
ROIC 7.38%
ROICexc 7.81%
ROICexgc 8.33%
OM 8.54%
PM (TTM) 5.15%
GM 32.07%
FCFM 5.64%
ROA(3y)8.18%
ROA(5y)3.66%
ROE(3y)15.96%
ROE(5y)7.2%
ROIC(3y)11.92%
ROIC(5y)N/A
ROICexc(3y)12.89%
ROICexc(5y)N/A
ROICexgc(3y)13.8%
ROICexgc(5y)N/A
ROCE(3y)15.07%
ROCE(5y)N/A
ROICexcg growth 3Y-0.51%
ROICexcg growth 5Y16.37%
ROICexc growth 3Y0.11%
ROICexc growth 5Y16.58%
OM growth 3Y-3.42%
OM growth 5Y2.33%
PM growth 3Y68.65%
PM growth 5Y-12.05%
GM growth 3Y-13%
GM growth 5Y-11.02%
F-Score4
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 3.53
Debt/EBITDA 1.06
Cap/Depr 104.37%
Cap/Sales 9.61%
Interest Coverage 250
Cash Conversion 85.89%
Profit Quality 109.35%
Current Ratio 1.46
Quick Ratio 0.84
Altman-Z 2.39
F-Score4
WACC7.99%
ROIC/WACC0.92
Cap/Depr(3y)91.58%
Cap/Depr(5y)68.62%
Cap/Sales(3y)7.67%
Cap/Sales(5y)7.01%
Profit Quality(3y)110.56%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.43%
EPS 3Y87.2%
EPS 5Y33.97%
EPS Q2Q%-24.19%
EPS Next Y6.62%
EPS Next 2Y18.58%
EPS Next 3Y19.52%
EPS Next 5YN/A
Revenue 1Y (TTM)1.57%
Revenue growth 3Y5.4%
Revenue growth 5Y21.88%
Sales Q2Q%-0.73%
Revenue Next Year-8.98%
Revenue Next 2Y-4.96%
Revenue Next 3Y-5.74%
Revenue Next 5YN/A
EBIT growth 1Y-29.74%
EBIT growth 3Y1.79%
EBIT growth 5Y24.73%
EBIT Next Year96.04%
EBIT Next 3Y23.1%
EBIT Next 5Y16.97%
FCF growth 1Y-46.33%
FCF growth 3Y7.94%
FCF growth 5Y14.96%
OCF growth 1Y-15.29%
OCF growth 3Y15.98%
OCF growth 5Y22.96%